胎盘母胎血管灌注不良与胎死及新生儿死亡的前瞻性研究
该研究在印度和巴基斯坦两个亚洲中心前瞻性纳入1633名有胎盘标本的孕妇,其中814例胎死、618例早产活产后新生儿死亡、201例足月活产。采用阿姆斯特丹共识框架评估胎盘,发现母体血管灌注不良在胎死(58.4%)和早产新生儿死亡(31.1%)中患病率高于足月活产(15.4%)。
要点
- 母体血管灌注不良与胎死风险升高相关,校正中心后相对危险度为3.88。
- 胎儿血管灌注不良在胎死中相对危险度为4.09,但在早产新生儿死亡中无显著差异。
- 合并母体高血压、小于胎龄儿或产前出血的胎死病例,母体血管灌注不良发生率更高。
核心结论
- 胎盘组织学检查,尤其针对灌注不良病变,对阐明早产儿胎死和新生儿死亡途径至关重要。
- 关注孕期胎盘母体和胎儿血管灌注不良,有助于识别胎死风险胎儿并降低胎死风险。
研究设计与样本
- 前瞻性观察性队列研究,在印度和巴基斯坦两个亚洲中心开展,2018年7月至2020年1月期间1633名有胎盘标本的孕妇提供知情同意。
- 纳入814例胎死、618例早产活产后新生儿死亡和201例足月活产,胎盘按阿姆斯特丹共识框架评估。
主要发现
- 母体血管灌注不良患病率:胎死58.4%、早产新生儿死亡31.1%、足月活产15.4%。
- 校正中心后,母体血管灌注不良在胎死vs足月活产的相对危险度为3.88(95%CI 2.70-5.59),早产新生儿死亡vs足月活产为2.07(95%CI 1.41-3.02)。
- 梗死和远端绒毛发育不全是母体血管灌注不良最常见的组织学成分。
- 胎儿血管灌注不良患病率:胎死19.0%、新生儿死亡8.3%、足月活产5.0%;校正中心后胎死vs足月活产相对危险度为4.09(95%CI 2.15-7.75),早产新生儿死亡vs足月活产为1.77(95%CI 0.90-3.49)。
- 母体血管灌注不良在合并母体高血压(71.4%)、小于胎龄儿(69.9%)、产前出血(59.1%)的胎死病例中高于无这些情况的胎死病例(43.3%);胎儿血管灌注不良在4类临床情况间无显著差异。
临床怎么用
- 对胎死和早产新生儿死亡病例应进行胎盘组织学检查,重点评估母体和胎儿血管灌注不良。
- 孕期关注胎盘灌注不良相关临床情况(母体高血压、小于胎龄儿、产前出血),有助于识别胎死高风险胎儿。
- 研究提示开发减少母胎血管灌注不良的干预措施,可能降低胎死和新生儿死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fetal death is one of the major adverse pregnancy outcomes and is common in low- and middle-income countries. Placental lesions may play an important role in the etiology of fetal and neonatal deaths. Previous research relating placental lesions to fetal death causation was hindered by a lack of agreement on a placental classification scheme. The Amsterdam consensus statement that was published in 2016 focused its attention on malperfusions in the maternal and fetal placental circulations. OBJECTIVE: This study aimed to investigate the relationships of placental maternal and fetal vascular malperfusions in fetal and neonatal deaths, focusing on the most important maternal clinical conditions in the pathway to fetal and neonatal deaths, such as maternal hypertension, antepartum hemorrhage, and decreased fetal growth. STUDY DESIGN: This was a prospective, observational cohort study conducted at 2 Asian sites. The data collected included clinical history, gross and histologic evaluations of the placenta, and several other investigations and were used to determine the cause of death. The placenta was evaluated at both sites using the Amsterdam consensus framework. We estimated the risk of placental maternal and fetal vascular malperfusions in fetal and neonatal deaths. RESULTS: Between July 2018 and January 2020 in India and Pakistan, 1633 women with placentas available for the study provided consent. Of these women, 814 had fetal deaths, 618 had preterm live births and subsequent neonatal deaths, and 201 had term live births. The prevalence of maternal vascular malperfusion was higher in the placentas associated with fetal deaths (58.4%) and preterm neonatal deaths (31.1%) than in the placentas associated with term live births (15.4%). Adjusting for site, maternal vascular malperfusion had a relative risk of 3.88 (95% confidence interval, 2.70-5.59) in fetal deaths vs term live births and a relative risk of 2.07 (95% confidence interval, 1.41-3.02) in preterm neonatal deaths vs term live births. Infarcts and distal villous hypoplasia were the most common histologic components of maternal vascular malperfusion. Compared with maternal vascular malperfusion (58.4%), fetal vascular malperfusion was less common in the placentas associated with fetal deaths (19.0%). However, there were higher frequencies of fetal vascular malperfusion in the placentas associated with fetal deaths (19.0%) than in placentas associated with neonatal deaths (8.3%) or term live birth (5.0%). Adjusting for site, fetal vascular malperfusion had a relative risk of 4.09 (95% confidence interval, 2.15-7.75) in fetal deaths vs term live births and a relative risk of 1.77 (95% confidence interval, 0.90-3.49) in preterm neonatal deaths vs term live births. Furthermore, there was a higher incidence of maternal vascular malperfusion in cases of maternal hypertension (71.4%), small for gestational age (69.9%), and antepartum hemorrhage (59.1%) than in cases of fetal deaths with none of these conditions (43.3%). There was no significant difference in the occurrence of fetal vascular malperfusion in the 4 clinical categories. CONCLUSION: Histologic examination of the placenta, especially for malperfusion disorders, is crucial in elucidating pathways to fetal and neonatal deaths in preterm infants. In particular, focusing on placental maternal and fetal vascular malperfusions during pregnancy is a means to identify fetuses at risk of fetal death and is an important strategy to reduce the risk of fetal death early delivery. We hope that the increased risk of fetal and neonatal deaths in these pregnancies can be reduced by the development of an intervention that reduces the likelihood of developing maternal and fetal vascular malperfusion.
引用
- Kulkarni VG, Sunilkumar KB, Nagaraj TS, et al. Maternal and fetal vascular lesions of malperfusion in the placentas associated with fetal and neonatal death: results of a prospective observational study. Am J Obstet Gynecol. 2021. PMID: 34111407. doi:10.1016/j.ajog.2021.06.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。